Evidence map›Paper›PMID 42346345›Full record

ArticleMetabolites2026

Untargeted Metabolomics and Metabolite-Gene Network Analysis Predict NF-κB Inhibition in Artemisian B-Treated Triple-Negative Breast Cancer Cells.

Shujun Shan, Ziyun Hu, Guimin Xue, Ping Yao, Peipei Du, Ruixi Gan, Junsong Wang

Abstract read
In one paragraph

Article in Metabolites, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shujun ShanCenter of Molecular Metabolism, Nanjing University of Science and Technology, Nanjing 210094, China.
Ziyun HuCenter of Molecular Metabolism, Nanjing University of Science and Technology, Nanjing 210094, China.
Guimin XueCollege of Pharmacy, Henan University of Chinese Medicine, Zhengzhou 450046, China.
Ping YaoDepartment of Pharmaceutical Engineering, Jiangsu Provincial Xuzhou Pharmaceutical Vocational College, Xuzhou 221116, China.
Peipei DuDepartment of Pharmaceutical Engineering, Jiangsu Provincial Xuzhou Pharmaceutical Vocational College, Xuzhou 221116, China.
Ruixi GanCenter of Molecular Metabolism, Nanjing University of Science and Technology, Nanjing 210094, China.
Junsong WangCenter of Molecular Metabolism, Nanjing University of Science and Technology, Nanjing 210094, China.ORCID 0000-0002-8935-4969

Funding

National Natural Science Foundation of China No. 81773857
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

apoptosisartemisian Bmetabolic reprogrammingmetabolite–gene network topologyNF-κB signalingtriple-negative breast canceruntargeted metabolomics

Identifiers

PMID42346345
PMCPMC13304393

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.